Michel J. Berg, M.D.

Dr. Michel J. Berg joined the University of Rochester School of Medicine and Dentistry faculty in 1993 and is currently an Associate Professor of Neurology. Dr. Berg is certified by several medical boards including the American Board of Psychiatry and Neurology, the subspecialty Board of Clinical Neurophysiology; and the American Board of Internal Medicine. He is a Fellow of the American Academy of Neurology.

Professional Background

Dr. Michel J. Berg joined the University of Rochester School of Medicine and Dentistry faculty in 1993 and is currently an Associate Professor of Neurology . He has a special interest in technology for healthcare. He is involved in projects on enhancing medication adherence with smart medication dispensers, establishing the equivalence of generic anti-epilepsy drugs (AED), automating MRI analysis, seizure prediction from EEG, and the genetics of abnormalities of brain development with a focus on cerebral cavernous malformations. He is the chair of the American Epilepsy Society Task Force on Continuity of Medication Supply which is currently focused on the issue of generic equivalence of anti-epilepsy drugs. He is on the Scientific Advisory Board of the Angioma Alliance. He is co-author of the text, 100 Maxims in Clinical Neuroradiology, and has authored and coauthored numerous scientific articles in the above fields.

Dr. Berg received a B.S. in Physics from Miami University in Oxford, Ohio. He obtained his M.D. from the University of Cincinnati College of Medicine and completed a residency in Internal Medicine at SUNY Health Science Center in Syracuse. At the University of Rochester, Dr. Berg completed both a residency in Neurology and a fellowship in Epilepsy. Dr. Berg is certified by several medical boards including the American Board of Psychiatry and Neurology, the subspecialty Board of Clinical Neurophysiology; and the American Board of Internal Medicine. He is a Fellow of the American Academy of Neurology.

Research